Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-22

FDA Approved: INVELTYS — Original Application (ALCON LABORATORIES, INC.)

View source ↗

Summary

FDA approved INVELTYS (loteprednol etabonate) ophthalmic suspension 1% from Alcon Laboratories as an original application for the treatment of postoperative ocu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVELTYS (LOTEPREDNOL ETABONATE)

Snippet

ORIG AP for INVELTYS (LOTEPREDNOL ETABONATE)